Abstract: Method for the production of dry, free-flowing, stable hydrophobin preparations by spraying and drying aqueous hydrophobin solutions, if appropriate comprising additives in a spray device.

Abstract: The present invention relates to pharmaceutical formulations for the production of chewable and suckable tablets, comprising agglomerates based on sugar or sugar alcohols and disintegrant and water-insoluble polymers in combination with a viscosity-increasing/gel-forming polymer, and the corresponding chewable and suckable tablets.

Abstract: Pharmaceutical formulation in the form of agglomerates comprising A) an excipient content composed of a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of a disintegrant, c) 1-15% by weight of water-insoluble, film-forming polymers d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients the total of the components a) to e) being 100% by weight, and B) at least one active ingredient.

Abstract: Pharmaceutical formulation in the form of agglomerates comprising A) an excipient content composed of a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of a disintegrant, selected from the group consisting of croscarmellose, sodium carboxymethylstarch and L-hydroxypropoylcellulose, c) 1-15% by weight of water-insoluble, film-forming polymers d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients the total of the components a) to e) being 100% by weight.

Abstract: Pharmaceutical formulation in the form of compacts comprising A) an agglomerated excipient content composed of a1) 60-97% by weight of sugar or sugar alcohols, a2) 1-25% by weight of a disintegrant, selected from the group consisting of crospovidone, croscarmellose, sodium carboxymethylstarch and L-hydroxypropylcellulose, a3) 1-15% by weight of water-insoluble, film-forming polymers a4) 0-15% by weight of water-soluble polymers and a5) 0-15% by weight of further pharmaceutically customary excipients, the total of the components a1) to a5) being 100% by weight, B) at least one active ingredient, C) 0 to 10% by weight, based on the total amount of A) to D), of a lubricant or mold release agent, and D), if appropriate, further pharmaceutical excipients.

Abstract: The present invention relates to a method for the production of solid solutions of sparingly soluble pesticides, pulverulent products that are obtained by said method and their use for pesticide formulations.

Abstract: The present patent application describes a method of regenerating a ruthenium catalyst for the hydrogenation of benzene, which comprises flushing the catalyst with inert gas in a regeneration step until the original activity or part of the original activity has been attained.

Abstract: A pharmaceutical formulation in the form of agglomerates comprising a) 60-97% by weight of sugar or sugar alcohols, b) 1-25% by weight of crosslinked polyvinylpyrrolidone, c) 1-15% by weight of water-insoluble, film-forming polymers, d) 0-15% by weight of water-soluble polymers and e) 0-15% by weight of further pharmaceutically customary excipients, the sum of the components a) to e) being 100% by weight.

Abstract: A process for producing solid solutions in powder or granule form of slightly soluble substances in which the slightly soluble substance is in the form of a molecular dispersion in an excipient matrix, by atomizing a solution of the active ingredient and of the matrix excipients, which comprises heating an aqueous suspension of the slightly soluble substance in the presence of the matrix excipients to temperatures above the boiling point under atmospheric pressure, and dissolving the slightly soluble substance, and subsequently converting the solution of the slightly soluble substance and of the matrix excipients by atomizing and drying into a solid form, where the temperature of the spray solution before feeding into the atomizing apparatus is 90° C. to 350° C.

Abstract: The invention relates to novel choline ascorbate-containing formulations; processes for their preparation and their use in human or animal foods, or human or animal food supplements or pharmaceuticals.

Abstract: Substantially solid compositions are provided having therein a compound with the structure of Formula I wherein A is a saturated ring formed by a plurality of atoms in addition to the N1 atom, the saturated ring atoms including at least one carbon atom and at least one of O, S, and N atoms, the substituent R1 bound to the N1 atom of the Formula I structure including either (a) a C1-24 alkyl or alkoxylated alkyl where the alkoxy is C2-4, (b) a C4-24 cycloalkyl, (c) a C7-24 alkaryl, (d) a repeating or nonrepeating alkoxy or alkoxylated alcohol, where the alkoxy unit is C2-4, or (e) —CR2R3C≡N where R2 and R3 are each H, a C1-24 alkyl, cycloalkyl, or alkaryl, or a repeating or nonrepeating alkoxyl or alkoxylated alcohol where the alkoxy unit is C2-4, the R2 and R3 substituents being each H, a C1-24 alkyl, cycloalkyl, or alkaryl, or a repeating or nonrepeating alkoxyl or alkoxylated alcohol where the alkoxy unit is C2-4, Z is a value in the range of 0 to 10, and wherein Y is monovalen

Abstract: The present invention relates to oral dosage forms comprising a) one or more active ingredients b) a formulated mixture of polyvinyl acetate and polyvinylpyrrolidone c) where appropriate other excipients customary for producing the dosage form, wherein they float on gastric fluid and display delayed release of active ingredient, and to the use and production thereof.

Abstract: Improved process for the preparation of granular N-alkylammoniumacetonitrile salts I R2R3N+R1—CR4R5—CN Y−  (I) where R1 to R5 are hydrogen or organic radicals, and Y− is a sulfate or hydrogensulfate anion, from an aqueous solution of the compound II R2R3N+R1—CR4R5—CN R6O—SO2—O−  (II) where R6 is C1- to C4-alkyl, which comprises evaporating this aqueous solution at a temperature of from 80° C. to 250° C. and a pressure of from 10 mbar to 2 bar to give a melt, then allowing the melt to solidify, where, during or following the evaporation, customary carrier materials and/or auxiliaries can be added, and the resulting solidified compound I is converted into the desired granular form.

Abstract: This invention relates to a pipe (1) having several internal ribs (2, 3, 4) having a spiral twist, where the ribs run with rotational symmetry with the longitudinal axis (5) of symmetry of the pipe (1). This invention creates a heat transfer pipe that will be characterized by a much better heat transfer in comparison with the previously known pipes having internal ribs, and to this end it guarantees not only an increase in the internal heat transfer surface area but also an effective cross-flow between the inside wall surface of the pipe and the core flow near the longitudinal axis of symmetry. To that end, the free ends (2c, 3c, 4c) of the internal ribs (2, 3, 4) are a distance (a) from the longitudinal axis (5) of symmetry of the pipe (1), which is in the range of 1:12 to 1:3 in relation to the inside diameter (d) of the pipe; and all the internal ribs (2, 3, 4) run in the same direction (arrow 6) and with the same spiral length (L) with a spiral twist to the longitudinal axis (5) of symmetry.

Abstract: A solid composition consisting essentially of 5-98 parts by weight of heterocyclic compounds I where L1 is groups with a cyclic carbamate, a lactonoxy or a lactam structure, X is a carbonyl, a doubled carbonyl or a heterocarbonyl group, and R1 is an organic radical or a second moiety L1, and/or oxime esters II where L2 is an oxime moiety where R2, R3 and Z4 are organic radicals or linkers, L3 is the radical R1, a second oxime moiety L2 or a carboxylic ester residue, carboxamide residue, phenolate residue, vinyloxy radical, sulfonamide residue, imidazole residue, amidolactam residue, cyclic carbamate residue, lactonoxy residue or lactam residue, and m is 0 or 1, and 2-95 parts by weight of inert porous carrier materials with an internal surface area of from 10 to 500 m2/g. The solid composition described is suitable as stable bleach activator component in detergents, bleaches and cleaners.

Abstract: 1 The invention concerns a solid composition substantially comprising between 5 and 98 parts by weight of heterocyclic compounds (I) R1—X—L1, wherein L1 stands for groups with a cyclic carbamate, a lactoneoxy or a lactam structure, X means a carbonyl, a double carbonyl or a heterocarbonyl group, and R1 designates an organic group or a second L1 group, and/or oxime esters (II), wherein L2 stands for an oxime group (a) or (b), R2, R3 and Z4 designating organic groups or bridge members, L3 stands for the R1 group, a second L2 oxime group or a carbon ester group, carbon amide group, phenolate group, vinyloxy group, sulphoneamide group, imidazole group, amidolactam group, cyclic carbamate group, lactoneoxy group or lactam group, and m means 0 or 1. The composition further comprises between 2 and 95 parts by weight of inert porous carrier materials with an internal area of between 10 and 500 m2/g.

Abstract: Textile detergent formulation, containing (A) from 0.1 to 10 wt % of quaternized glycine nitriles, (B) from 0.5 to 40 wt % of bleaches in the form of peroxo compounds and/or peracids, (C) from 0.5 to 50 wt % of non-ionic and/or anionic surfactants and (D) from 5 to 85 wt % of compounds that are capable of sequestering calcium and/or magnesium ions. This formulation is suitable for domestic and commercial laundering of textiles in a dosage of more than 2 g per liter of washing liquor, particularly when using a goods-to-liquor ratio of from 1:10 to 1:2.

Abstract: Micropowders having spherical particles possessing an essentially smooth surface structure contain, as essential components, polyarylene ether sulfones or polyarylene ether ketones and are obtainable by prilling melts thereof or spray-drying solutions thereof.